---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-316225"
form_type: "8-K"
ticker: "RNTX"
cik: "0001420565"
company_name: "Rein Therapeutics, Inc."
filed_at: "2025-12-11T23:59:59+00:00"
generated_at: "2026-05-16T13:29:10.464467+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Rein Therapeutics terminates Yorkville equity facility; $3M drawn, no penalties

## Summary
- Terminated Pre-Paid Advance and Standby Equity Purchase Agreements with Yorkville on Dec 11, 2025.
- Total $3M in advances drawn under PPA; most recent advance on Oct 23, 2025.
- No sales of common stock executed under the Standby Equity Purchase Agreement.
- No penalties or fees incurred in connection with the termination.

## SEC filing metadata
- accession: 0001193125-25-316225
- form_type: 8-K
- ticker: RNTX
- cik: 0001420565
- company_name: Rein Therapeutics, Inc.
- filed_at: 2025-12-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420565/000119312525316225/0001193125-25-316225-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420565/000119312525316225/d783815d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-316225
- JSON: https://secwatch.observer/filing/0001193125-25-316225.json
- Plain text: https://secwatch.observer/filing/0001193125-25-316225.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.